Suppr超能文献

影响颅内动脉瘤性蛛网膜下腔出血患者生存的因素:一项长期观察性队列研究。

Predictors of survival after aneurysmal subarachnoid hemorrhage: The long-term observational cohort study.

机构信息

Department of Neurosurgery and Spine Surgery, University Hospital of Essen, Hufelandstraße 55, Essen 45147, Germany.

Department of Neurosurgery and Spine Surgery, Evangelisches Krankenhaus Oldenburg, Steinweg 13, Oldenburg 26122, Germany.

出版信息

Clin Neurol Neurosurg. 2024 Dec;247:108605. doi: 10.1016/j.clineuro.2024.108605. Epub 2024 Oct 20.

Abstract

OBJECTIVE

Despite recent advances in neuro-intensive care, there is still considerable mortality in patients with aneurysmal subarachnoid hemorrhage (SAH). In this long-term monocentric observational cohort study, we aimed to analyze the rates, timing, and predictors of mortality after SAH.

METHODS

All consecutive SAH cases treated between January 2003 and June 2016 were included. Patients' demographic characteristics, previous medical history, SAH-related parameters, and available post-treatment follow-up data were collected and evaluated as potential mortality predictors in univariate and multivariate analyses.

RESULTS

Of 992 patients, 179 died during the initial treatment and 33 during the follow-up time reaching an overall mortality rate of 21.4 %. Of over 119 tested variables, we identified the following independent predictors in the final multivariate Cox regression analysis: age >55 years (p<0.0001); World Federation of Neurosurgical Societies (WFNS) admission grade IV or V (p=0.025); Hijdra sum score ≥15 points (p=0.003); intracranial pressure (ICP) increase (p<0.0001); and delayed cerebral ischemia (DCI) (p<0.0001). Being exposed to all five risk factors resulted in the case fatality rate of 75 % within a median survival of 14 days, compared to 2.5 % within a median of 1525 days when none of these features were present.

CONCLUSIONS

The initial impact of aneurysmal bleeding is amongst the major mortality causes after SAH. Of potentially preventable adverse events, ICP increase and DCI occurring during initial treatment also present eminent clinical relevance for patients' survival in the long-term follow-up. Further ICP and DCI management optimization might help to decrease the mortality rate after SAH.

摘要

目的

尽管神经重症监护领域取得了近期进展,但动脉瘤性蛛网膜下腔出血(SAH)患者的死亡率仍然相当高。在这项长期的单中心观察性队列研究中,我们旨在分析 SAH 后的死亡率、时间和预测因素。

方法

纳入 2003 年 1 月至 2016 年 6 月期间连续收治的所有 SAH 患者。收集患者的人口统计学特征、既往病史、SAH 相关参数和可获得的治疗后随访数据,并在单变量和多变量分析中评估其作为潜在死亡率预测因素的价值。

结果

992 例患者中,179 例在初始治疗期间死亡,33 例在随访期间死亡,总死亡率为 21.4%。在超过 119 个测试变量中,我们在最终的多变量 Cox 回归分析中确定了以下独立预测因素:年龄>55 岁(p<0.0001);世界神经外科学会联合会(WFNS)入院分级 IV 或 V 级(p=0.025);Hijdra 评分≥15 分(p=0.003);颅内压(ICP)升高(p<0.0001);和迟发性脑缺血(DCI)(p<0.0001)。如果患者存在这 5 个危险因素,则中位生存时间 14 天内的病死率为 75%,而如果这些特征均不存在,则中位生存时间 1525 天内的病死率为 2.5%。

结论

SAH 后初始出血的影响是导致患者死亡的主要原因之一。在可能预防的不良事件中,初始治疗期间发生的 ICP 升高和 DCI 对患者的长期生存也具有重要的临床意义。进一步优化 ICP 和 DCI 管理可能有助于降低 SAH 后的死亡率。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验